Firefly Neuroscience (AIFF) Shares Outstanding (Weighted Average) (2010 - 2026)

Firefly Neuroscience has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 60.82% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (down 60.82% YoY), and the FY2025 full-year result was $900738.0, down 54.31% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $3.9 million, up from $900738.0 in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $17.3 million in Q1 2022, with the low at $54708.0 in Q4 2022.
• Average Shares Outstanding (Weighted Average) over 5 years is $6.0 million, with a median of $3.9 million recorded in 2026.
• Year-over-year, Shares Outstanding (Weighted Average) sank 99.56% in 2022 and soared 919.07% in 2024.
• Tracing AIFF's Shares Outstanding (Weighted Average) over 5 years: stood at $54708.0 in 2022, then soared by 253.57% to $193433.0 in 2023, then soared by 919.07% to $2.0 million in 2024, then sank by 54.31% to $900738.0 in 2025, then jumped by 333.06% to $3.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $3.9 million (Q1 2026), $900738.0 (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.

Peer Comparison